Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/19/1999 | WO1999041370A1 Cea/nca-based differentiation cancer therapy |
08/19/1999 | WO1999041369A2 Genetic vaccine vector engineering |
08/19/1999 | WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines |
08/19/1999 | WO1999041364A2 Compositions and methods for wound healing |
08/19/1999 | WO1999041360A1 Method for the development of an hiv vaccine |
08/19/1999 | WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
08/19/1999 | WO1999041281A1 Modulation of hedgehog-mediated signaling pathway |
08/19/1999 | WO1999041280A1 METHOD FOR PURIFYING PrPres FROM A BIOLOGICAL SAMPLE AND APPLICATIONS |
08/19/1999 | WO1999041007A2 Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
08/19/1999 | WO1999040881A2 Specific antibodies against mammary tumor-associated mucin, method for production and use |
08/19/1999 | WO1999040837A2 Compositions for detecting and surgically removing lymphoid tissue involved in tumor progression |
08/19/1999 | WO1999031141A3 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof |
08/19/1999 | WO1999028603A3 Measurement of contaminant components in exhaust gas and reduction of excessive contaminant emissions during cold starts and while driving |
08/19/1999 | WO1999025380A3 Methods and compositions for the treatment of psoriasis |
08/19/1999 | WO1999024394A3 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
08/19/1999 | WO1999023466A3 Apparatus and methods for measuring fluorescence polarization |
08/19/1999 | WO1999023108A9 Inducible phosphofructokinase and the warburg effect |
08/19/1999 | WO1999019276A3 Molecular compounds having complementary surfaces to targets |
08/19/1999 | WO1999016907A3 Reagent and method for attaching target molecules to a surface |
08/19/1999 | WO1999015894A3 Method of identification of leads or active compounds |
08/19/1999 | WO1999014576A3 Isotopic gas analyzer |
08/19/1999 | WO1999004266A3 Interactions of atm, atr or dna-pk with p53 |
08/19/1999 | WO1998055110A3 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION |
08/19/1999 | WO1998050423A3 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis |
08/19/1999 | WO1997036994A8 Sensor and modified membrane for the sensor |
08/19/1999 | DE19807608A1 Measuring level of protein biosynthesis using photoprotein loaded with co-factor during translation as reporter for screening for biologically active compounds |
08/19/1999 | DE19806642A1 Biosensor for specific binding assays, having organic hydrogel passivation layer |
08/19/1999 | DE19806185A1 Immunoassay und Testkit zur Bestimmung von fucosyliertem Protein in einer biologischen Probe And Immunoassay Kit for the detection of protein in a biological sample fucosyliertem |
08/19/1999 | DE19806167A1 Edelmetall-geschützte, antikorrosive magnetische Nanokolloide Precious metal protected anticorrosive magnetic nano colloids |
08/19/1999 | DE19806054A1 Test card to determine concentration of substance in body fluids |
08/19/1999 | DE19806035A1 Determination of effectiveness of irradiation wavelength(s) in light-driven reaction(s) in probe position(s) |
08/19/1999 | DE19805612A1 Controlled production or modification of polymer, especially hydrogenation of nitrile rubber |
08/19/1999 | DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer |
08/19/1999 | CA2745932A1 Methods for predicting pregnancy outcome in a subject by hcg assay |
08/19/1999 | CA2323011A1 Method for the development of an hiv vaccine |
08/19/1999 | CA2321160A1 Methods and compositions for diagnosis of hepatoma |
08/19/1999 | CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
08/19/1999 | CA2321105A1 Human short-chain tnf-receptor family protein |
08/19/1999 | CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines |
08/19/1999 | CA2320958A1 Antigen library immunization |
08/19/1999 | CA2320940A1 Anticorrosive magnetic nanocolloids protected by precious metals |
08/19/1999 | CA2320753A1 Method for detecting intimin producing microorganisms |
08/19/1999 | CA2320626A1 Genetic vaccine vector engineering |
08/19/1999 | CA2320431A1 Targeting of genetic vaccine vectors |
08/19/1999 | CA2320427A1 Human receptor proteins |
08/19/1999 | CA2320422A1 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
08/19/1999 | CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
08/19/1999 | CA2319688A1 Specific antibodies against mammary tumor-associated mucin, method for production and use |
08/19/1999 | CA2319167A1 Interaction between cyclin d1 and steroid receptor co-activators |
08/19/1999 | CA2319098A1 Cea/nca-based differentiation cancer therapy |
08/19/1999 | CA2309705A1 Serological diagnosis of chagas' disease |
08/18/1999 | EP0936467A2 Exhaust gas analyzer and modal mass analysis method by gas trace process using the analyzer thereof |
08/18/1999 | EP0936465A2 Method and measuring device for testing the reaction of metal samples to hydrogen |
08/18/1999 | EP0935789A1 System, method, and computer program product for the visualization and interactive processing and analysis of chemical data |
08/18/1999 | EP0935784A2 System, method and computer program product for identifying chemical compounds having desired properties |
08/18/1999 | EP0935757A1 Assessment of cervical cells |
08/18/1999 | EP0935756A2 Monitoring reactivity of thyroid peroxidase autoantibodies |
08/18/1999 | EP0935755A1 Use of abp as a prognostic and diagnostic indicator |
08/18/1999 | EP0935754A1 Compositions and methods for detection of antibody binding to cells |
08/18/1999 | EP0935753A1 Assay and cell line for the identification of growth hormone mimetics |
08/18/1999 | EP0935752A1 Methods for in vitro determination of erythropoietin bioactivity |
08/18/1999 | EP0935751A1 Process for determining the lubricant power of lubricant oils |
08/18/1999 | EP0935750A1 Testing device and method of use |
08/18/1999 | EP0935749A1 A method and flow system for spectrometry and a cuvette for the flow system |
08/18/1999 | EP0935746A1 Test device for bodily fluids |
08/18/1999 | EP0935679A1 Method for chromosome classification by decorrelation statistical analysis and hardware therefore |
08/18/1999 | EP0935677A1 Method for preparing assay supports having an ordered set of reaction zones |
08/18/1999 | EP0935676A2 Method of identifying cytochrome p450 |
08/18/1999 | EP0935673A1 Methods and devices for mass transport assisted optical assays |
08/18/1999 | EP0935671A1 Methods for preparing arrays of single-stranded dna |
08/18/1999 | EP0935662A2 Multiple epitope fusion protein |
08/18/1999 | EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
08/18/1999 | EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
08/18/1999 | EP0935656A1 Hedgehog interacting proteins and uses related thereto |
08/18/1999 | EP0935655A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
08/18/1999 | EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
08/18/1999 | EP0935650A1 Detection of mammalian heparanase activity and purification of mammalian heparanase |
08/18/1999 | EP0935649A1 Artificial rheumatic pannus tissues and diagnostic method for detecting rheumatoid arthritis |
08/18/1999 | EP0935610A1 Novel human interferon-inducible protein |
08/18/1999 | EP0935609A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
08/18/1999 | EP0935608A1 Cytotoxic peptides |
08/18/1999 | EP0935605A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
08/18/1999 | EP0935604A1 Magnetically activated cell sorting for production of proteins |
08/18/1999 | EP0935495A1 An apparatus and method for detecting and handling liquid separation in liquid emulsions |
08/18/1999 | EP0935470A1 Method for treating allergic lung disease |
08/18/1999 | EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
08/18/1999 | EP0935412A1 Composition and method for treating plants with exogenous chemicals |
08/18/1999 | EP0871393A4 In situ immunodetection of antigens |
08/18/1999 | EP0828861B1 On-line production control of cast irons by measuring the surface tension of the base treated iron |
08/18/1999 | EP0792292B1 Orphan receptor |
08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
08/18/1999 | EP0772692A4 Methods of identifying patients having an altered immune status |
08/18/1999 | EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
08/18/1999 | EP0623175B1 Detection of reverse transcriptase by dna hybridization assay |
08/18/1999 | EP0584267B1 Tumor associated monoclonal antibody 81av78 |
08/18/1999 | CN1226317A Chromatographic assay or test device |
08/18/1999 | CN1226316A Method of detecting gynecological carcinomas |
08/18/1999 | CN1226171A Type-2 chemokine binding proteins and methods of use thereof |